[go: up one dir, main page]

PT85386A - Processo para a preparacao de um agente para a terapia da hemofilia a resistente ao factor viii - Google Patents

Processo para a preparacao de um agente para a terapia da hemofilia a resistente ao factor viii

Info

Publication number
PT85386A
PT85386A PT85386A PT8538687A PT85386A PT 85386 A PT85386 A PT 85386A PT 85386 A PT85386 A PT 85386A PT 8538687 A PT8538687 A PT 8538687A PT 85386 A PT85386 A PT 85386A
Authority
PT
Portugal
Prior art keywords
agent
factor viii
preparing
solution
appropriate
Prior art date
Application number
PT85386A
Other languages
English (en)
Other versions
PT85386B (pt
Inventor
Norbert Heimburger
Karl-Heinz Wenz
Wilfried Wormsbacher
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6305910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT85386(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT85386A publication Critical patent/PT85386A/pt
Publication of PT85386B publication Critical patent/PT85386B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT85386A 1986-07-24 1987-07-23 Processo para a preparacao de um agente para a terapia da hemofilia a resistente ao factor viii PT85386B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863625090 DE3625090A1 (de) 1986-07-24 1986-07-24 Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
PT85386A true PT85386A (pt) 1988-07-29
PT85386B PT85386B (pt) 2001-05-31

Family

ID=6305910

Family Applications (1)

Application Number Title Priority Date Filing Date
PT85386A PT85386B (pt) 1986-07-24 1987-07-23 Processo para a preparacao de um agente para a terapia da hemofilia a resistente ao factor viii

Country Status (12)

Country Link
US (1) US5091363A (pt)
EP (1) EP0255651B1 (pt)
JP (1) JP2535547B2 (pt)
AT (1) ATE73673T1 (pt)
AU (1) AU607924B2 (pt)
CA (1) CA1321139C (pt)
DE (2) DE3625090A1 (pt)
DK (1) DK166652B1 (pt)
ES (1) ES2037035T3 (pt)
FI (1) FI87044C (pt)
GR (1) GR3004868T3 (pt)
PT (1) PT85386B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03215430A (ja) * 1990-01-19 1991-09-20 Kita Kiyoshi 関節腔抗凝固剤
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
CA2090738C (en) * 1993-02-24 1996-05-21 Hema-Quebec Use of paf
US7582712B1 (en) 2008-05-09 2009-09-01 Formosa Plastics Corporation, U.S.A. Alpha-olefins polymerization catalyst
CN108226540B (zh) * 2018-02-08 2020-07-03 武汉市长立生物技术有限责任公司 一种鞣花酸试剂及其配制方法与活化部分凝血活酶时间测定试剂、aptt试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2550011C2 (de) * 1975-11-07 1982-11-25 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines antihämophilen Mittels
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
JPS5770814A (en) * 1980-10-17 1982-05-01 Isamu Horikoshi Oral preparation of blood clotting eighth factor
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
DE3481109D1 (de) * 1983-05-09 1990-03-01 Novo Nordisk As Antihaemophilie-faktor-viii-konzentrat und dessen herstellungsverfahren.
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
US4610880A (en) * 1983-06-27 1986-09-09 Queen's University At Kingston Composition for controlling hemophilia in mammals
US4536392A (en) * 1983-06-27 1985-08-20 Queen's University At Kingston Method for controlling hemophilia in mammals
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing

Also Published As

Publication number Publication date
ES2037035T3 (es) 1993-06-16
DK384687A (da) 1988-01-25
ATE73673T1 (de) 1992-04-15
FI87044B (fi) 1992-08-14
DK166652B1 (da) 1993-06-28
FI873222A (fi) 1988-01-25
DE3777482D1 (de) 1992-04-23
FI873222A0 (fi) 1987-07-22
JP2535547B2 (ja) 1996-09-18
PT85386B (pt) 2001-05-31
AU607924B2 (en) 1991-03-21
DE3625090A1 (de) 1988-01-28
US5091363A (en) 1992-02-25
EP0255651B1 (de) 1992-03-18
GR3004868T3 (pt) 1993-04-28
EP0255651A2 (de) 1988-02-10
JPS6345224A (ja) 1988-02-26
CA1321139C (en) 1993-08-10
AU7604987A (en) 1988-01-28
DK384687D0 (da) 1987-07-23
EP0255651A3 (en) 1989-10-11
FI87044C (fi) 1992-11-25

Similar Documents

Publication Publication Date Title
NO871361L (no) Fremgangsmaate for redusering av vaesketap i sementblandinger som kan inneholde betydelige saltkonsentrasjoner.
SE8206168D0 (sv) Preparations and process for preparation thereof
MX162265A (es) Procedimiento mejorado para la preparacion de acido 4-dimetilamino-1-hidro-xibutano-1,1-difosfonico
ES2081488T3 (es) Uso de fosfolipido en la fabricacion de un medicamento topico para modificar los niveles de colesterol serico.
DE3852140D1 (de) Produktion von Proteinen in aktiven Formen.
TR26748A (tr) SU VE N-METIL-MORFOLIN-N-OKSIT ICINDE SELüLOZ CÖZELTISI.
PT85386A (pt) Processo para a preparacao de um agente para a terapia da hemofilia a resistente ao factor viii
FI843909A0 (fi) Foerfarande foer pastoerisering av plasma eller av koncentrat av blodkoaguleringsfaktorerna ii, vii, ix och x.
MX165470B (es) Agentes de carbonatacion de aminoazucares y preparacion
ES2147830T3 (es) Procedimiento para la preparacion de pigmentos de diarildicetopirrolopirrol.
ES2011779B3 (es) Procedimiento e instalacion para limpieza de gases de humo con contenido de so2
BR8705927A (pt) Processo aperfeicoado para oxidar de maneira substancialmente completa o vapor de alcool e/ou formaldeido contido na mistura de gas de escape aquecida de um motor movido a alcool;e processo para oxidar de maneira substancialmente completa e catalitica uma mistura de vapor de alcool e/ou vapor de formaldeido contida em um gas carreador aquecido
BR8706782A (pt) Banhos para o polimento quimico de superficies de aco inoxidavel e processo para o polimento de uma superficie de aco inoxidavel
BR9005230A (pt) Composicao aquosa para tratamento de cabelo e processo para distribuicao de um composto nao acido que tem um peso molecular nao acima de 5.000
KR860004828A (ko) 안트라퀴논 분산액의 제조방법
BR7508676A (pt) Aperfeicoamento em processo para tratamento de vapor d'agua gerado na concentracao de uma solucao aquosa de ureia
ATE111891T1 (de) Verfahren zur herstellung von 3- nitrobenzolsulfonsäurechlorid.
PT81908B (pt) Processo para a fabricacao de carbonato de sodio anidro denso
ATE42094T1 (de) Verbesserte verfahren zur herstellung von d-threo-1-(p-methylsulfonylphenyl)-2-dichlorace amido- propandiol-1,3-(thiamphenicol)sowie verwendung geeigneter zwischenprodukte.
ES506694A0 (es) Procedimiento para tratar madera
ATE60055T1 (de) Verfahren zur herstellung von n-methyl-lysergol.
ATE1239T1 (de) Verfahren zur herstellung von 4-amino-5-chlor-1-phenyl-pyridazon-(6).
DE3376630D1 (en) Process for the local and far-reaching influence of chemical and/or physical reactions in the atmosphere
ZA912829B (en) Process for the removal of cholesterol from egg yolk
EP0262063A3 (en) Process for stabilizing chlorination mixtures of phenol and/or chlorophenols

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 20010215

MM3A Annulment or lapse

Effective date: 20050816